Specifically, ApoE4, present in approximately 13.3% of the population, is identified as the strongest genetic risk factor for late-onset Alzheimer’s Disease (AD) [14] and is associated with increased severity of neuropathy in diabetic patients [15, 16]. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.